Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.
Open Access
- 1 May 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 83 (5) , 1598-1604
- https://doi.org/10.1172/jci114057
Abstract
The present study was designed to elucidate the molecular genetic basis of a familial deficiency of alpha 2-plasmin inhibitor (alpha 2PI). Southern blot hybridization analysis with human alpha 2PI cDNA and genomic DNA probes demonstrated no gross deletion or rearrangement of the gene. By sequencing all the coding exons and exon-intron boundaries of the gene of a homozygote, we identified a single cytidine nucleotide insertion in the exon coding for the carboxyl-terminal region. This frameshift mutation leads to an alteration and elongation of the carboxyl-terminal portion of the deduced amino acid sequence. Synthetic oligonucleotide probes confirmed this frameshift mutation in all the affected family members including both heterozygous parents. In a transient expression assay, the alpha 2PI level in the culture medium of the cells transfected with the mutated alpha 2PI expression vector was very low and only 4% of that of the cells transfected with the normal vector, although the transcript levels and the cellular contents of alpha 2PIs did not differ significantly. Elongation of amino acid sequence in the mutant alpha 2PI was confirmed by an analysis of alpha 2PI in a transient expression experiment. These data indicate that this mutation is the cause of alpha 2PI deficiency in this pedigree.This publication has 34 references indexed in Scilit:
- Hemostasis associated with abnormalities of fibrinolysisBlood Reviews, 1989
- Organization of the human alpha 2-plasmin inhibitor gene.Proceedings of the National Academy of Sciences, 1988
- SV40-transformed simian cells support the replication of early SV40 mutantsCell, 1981
- FIBRINOLYTIC STATES IN A PATIENT WITH CONGENITAL DEFICIENCY OF ALPHA-2-PLASMIN INHIBITOR1980
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *Journal of Clinical Investigation, 1979
- Natural inhibitors of fibrinolysisProgress in Cardiovascular Diseases, 1979
- EB virus-induced B lymphocyte cell lines producing specific antibodyNature, 1977
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states.Journal of Clinical Investigation, 1977
- Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.Journal of Biological Chemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970